Detection of Upper Gastrointestinal (GI) Bleeding With a Novel Bleeding Sensor Capsule [DING]

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 11, 2015

Primary Completion Date

February 24, 2016

Study Completion Date

February 29, 2016

Conditions
Upper GI Bleeding
Interventions
DIAGNOSTIC_TEST

HemoPill acute

Capsule is swallowed by the patient and an external study receiver records the capsule sensor data for 4 consecutive hours. Patients undergo endoscopy within 12 hours after capsule ingestion. Afterwards, the endoscopic findings (endoscopy pictures and patient's endoscopy report) are compared to the sensor capsule data results. Capsule excretion is monitored for up to 4 days. If excretion is not recorded during that time, a follow-up examination of the patient is conducted after 10 days.

Trial Locations (1)

Unknown

Department of Gastroenterology and Oncology, Klinikum Ludwigsburg, Ludwigsburg

All Listed Sponsors
lead

Ovesco Endoscopy AG

INDUSTRY

NCT03176407 - Detection of Upper Gastrointestinal (GI) Bleeding With a Novel Bleeding Sensor Capsule [DING] | Biotech Hunter | Biotech Hunter